{"schema_version":"1","generated_at":"2026-11-01T02:48:17.973Z","data_as_of":null,"url":"https://www.findmykol.com/kol/anthony-serritella","json_url":"https://www.findmykol.com/kol/anthony-serritella/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"anthony-serritella","name":"Anthony Serritella","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Wisconsin–Madison","institution_url":"https://www.findmykol.com/institution/university-of-wisconsin-madison","city":"Madison","state":"WI","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1265822928","orcid":"0009-0006-9887-3054","openalex":"A5078448821"},"summary":"Anthony Serritella is an Oncology physician affiliated with University of Wisconsin–Madison. OpenAlex indexes 91 publications with 854 citations (h-index 12).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":91,"cited_by_count":854,"h_index":12,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":3,"program_years":{"first":2021,"last":null},"rows_total":0,"shown":0,"withheld":0,"rows":[],"record_url":"https://openpaymentsdata.cms.gov/search?query=1265822928","source":"payments"},"prescribing":{"data_year":2020,"areas_total":5,"areas_shown":3,"areas":[{"area":"Cardiovascular","share_pct":46.8,"classes_total":6,"classes":[{"class":"Statin","setting":"prescribed","share_pct":13.3,"drugs":[{"name":"Atorvastatin Calcium","share_pct":100}],"max_beneficiaries":17},{"class":"Calcium channel blocker","setting":"prescribed","share_pct":12.9,"drugs":[{"name":"Amlodipine Besylate","share_pct":100}],"max_beneficiaries":15}]},{"area":"Nervous system","share_pct":20.9,"classes_total":3,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":9.9,"drugs":[{"name":"Tramadol Hcl","share_pct":100}],"max_beneficiaries":null},{"class":"Gabapentinoids","setting":"prescribed","share_pct":6.5,"drugs":[{"name":"Gabapentin","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":20.2,"classes_total":3,"classes":[{"class":"Anticholinergic","setting":"prescribed","share_pct":7.6,"drugs":[{"name":"Dicyclomine Hcl","share_pct":100}],"max_beneficiaries":null},{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":6.8,"drugs":[{"name":"Omeprazole","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2020,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Metastatic progression and toxicity in high-risk clear cell renal cell carcinoma patients treated with adjuvant pembrolizumab at a tertiary care center.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.7_suppl.471","status":"verified"},{"title":"Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2)","year":2024,"journal":"Prostate Cancer and Prostatic Diseases","source_url":"https://doi.org/10.1038/s41391-024-00901-4","status":"verified"},{"title":"Therapeutic implications of homologous repair deficiency testing in patients with prostate cancer (Part 2 of 2)","year":2024,"journal":"Prostate Cancer and Prostatic Diseases","source_url":"https://doi.org/10.1038/s41391-024-00887-z","status":"verified"},{"title":"A Phase I Trial of Enzalutamide Plus Selective Glucocorticoid Receptor Modulator Relacorilant in Patients with Metastatic Castration-Resistant Prostate Cancer","year":2024,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1078-0432.ccr-23-3636","status":"verified"},{"title":"Large Cell Neuroendocrine Prostate Cancer: Large Is Not Small","year":2024,"journal":"The Oncologist","source_url":"https://doi.org/10.1093/oncolo/oyad344","status":"verified"}],"source":"works"},"similar":[{"name":"Justine Bruce","slug":"justine-bruce","institution":"University of Wisconsin–Madison","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/justine-bruce","json_url":"https://www.findmykol.com/kol/justine-bruce/profile.json"},{"name":"Mark Albertini","slug":"mark-albertini","institution":"University of Wisconsin–Madison","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/mark-albertini","json_url":"https://www.findmykol.com/kol/mark-albertini/profile.json"},{"name":"Anne Traynor","slug":"anne-traynor","institution":"University of Wisconsin–Madison","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/anne-traynor","json_url":"https://www.findmykol.com/kol/anne-traynor/profile.json"},{"name":"Rebecca Richards","slug":"rebecca-richards","institution":"University of Wisconsin–Madison","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rebecca-richards","json_url":"https://www.findmykol.com/kol/rebecca-richards/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2020}},"methodology_url":"https://www.findmykol.com/about#methodology"}